Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II M7824 Monotherapy in Advanced Biliary Tract Cancer After Platinum Failure
jRCT2080224605Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- Mar 2019
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01
Overview
Phase 2, open-label, single-arm trial of bintrafusp alfa in biliary cancer, sponsored by Merck KGaA. Started Mar 2019; status: completed.
02
Drugs
bintrafusp alfa
03
Conditions
biliary cancer
Beyond the preview
Go deeper on jRCT2080224605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224605.